Article Figures & Data
Figures
- Figure 1.
Scatter plot of COVID-19–related CFRs from series comparing rates from patients with cancer (red dots) with patients without cancer (gray dots). [Series includes publications from Sng et al. (2); Cattaneo et al. (7); Meng et al. (9); Mehta et al. (11); Brar et al. (6); Ruthrich et al. (4); Lunski et al. (5); Tian et al. (10); Wang et al. (3); and Dai et al. (12)].
- Figure 2.
Forest plot of series reporting hazard ratios (HR; top in red) or odds ratios (OR; bottom in blue) for death, or severity of COVID-19 in the case of the Tian series, in patients with COVID-19 and cancer compared with no cancer. The size of the symbol is proportional to the number of individuals in each series. The line represents the lower and upper limits of the 95% confidence intervals. Negative HR or OR values favor decreased risk for death, whereas positive values represent increased risk for death or severity of COVID-19. [Series includes publications from Meng et al. (9); Williamson et al. (8); Mehta et al. (11); Williamson et al. (8); Sng et al. (2); Brar et al. (6); Tian et al. (10); Dai et al. (12); and Lunski et al. (5)].
Additional Files
Supplementary Data
- Tables S1-S4 - Supplemental Table S1. Studies comparing outcomes among SARS-COV-2 infected patients with cancer and those without cancer. Supplemental Table S2. Studies comparing outcomes among SARS-COV-2 infected patients with cancer and uninfected patients with cancer Supplemental Table S3. Studies reporting outcomes among SARS-COV-2 infected patients with cancer without any comparison Supplemental Table S4. Metanalyses of published studies on COVID-19-cancer connection
- AACR COVID-19 and Cancer Task Force - AACR COVID-19 and Cancer Task Force
- AACR COVID-19 and Cancer Task Force Bios - AACR COVID-19 and Cancer Task Force Bios
Volume 11, Issue 2
